Indefinite Delivery Contract SPE2DX16D9412

The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, under the SPE2DB program, provides the DLA with firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The products covered include branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract positions DMS Pharmaceutical Group as a critical supplier in the federal pharmaceutical supply chain, enabling direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites. The contract has an ultimate completion date of November 2026 and does not utilize any set-aside designations.

The task orders awarded under this IDC demonstrate the breadth of pharmaceutical products DMS Pharmaceutical Group supplies to the DLA, including specialized medications such as Xolair, Trikafta, Keytruda, Botox, and Nucala. These delivery orders, valued from thousands to tens of thousands of dollars, are predominantly awarded on a firm fixed-price basis and cover a wide range of medical needs, including oncology treatments, contraceptives, auto-injectors, and other specialized pharmaceutical items. The place of performance for these task orders is consistently the prime contractor's facility in Park Ridge, Illinois.